// App-Quantinova.ai

T069 : Post‐hoc comparison of best‐corrected visual acuity improvement in study and untreated fellow eyes with active non‐infectious uveitis of the posterior segment in the SAKURA program

Researchers

Presenter

  • B. Bodaghi

Principal Investigators

  • C. Pavesio

  • A. Abraham

Medical Centers

  • Hopital Pitie-Salpetriere, Ophtalmologie, Paris, France

  • Moorfelds Eye Hospital, Medical Retina, London, United Kingdom

  • Santen Inc., Global Clinical Development, Emeryville, United States

Locations

  • France

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Uveitis

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved